To improve patients’ experiences of opioid tapers, an increasingly common intervention, tapering plans should be based on individualized risk-benefit assessments & involve patient-centered approaches & improved provider communication Angela Bazzi link.springer.com/article/10.100…

New: results of a randomized mixed methods QI evaluation for people with A1c above goal in type 2 diabetes, combining CGM and low carb coaching in a family medicine outpatient setting. MCT2D | Michigan Collaborative for Type 2 Diabetes Dina Hafez Griauzde U-M Family Medicine

I was talking to a patient recently about her different experiences using heroin vs fentanyl. She’s been using opioids a long time. Too long, by her count. She explained the difference to me like this (shared with permission): 1/x

ATTN: Board-certified/board-eligible internists & social scientists looking to develop & conduct independently funded research focused on #HealthServices & #HealthPolicy. Check out this opportunity & add'l open positions in the General Medicine Division. medicine.umich.edu/dept/intmed/di…

Proud of my mentor!

Thank you, Mayor Christopher Taylor (he/him), for adding to the excitement of our #GroundhogDay2023 ceremony at Burns Park Elementary! @A2SchoolsSuper City of Ann Arbor Michigan Dept of Ed Michigan Schools

14 months ago I had to evacuate from Oxford High Schol when a fifteen year old opened fire and killed four of my classmates and injured seven more. Tonight, I am sitting under my desk at Michigan State Univeristy, once again texting everyone “I love you” When will this end?

Great to see other journalists finally picking this story up nbcnews.com/health/health-… but so many are still enthusiastically repeating myths about pain and opioids

Kurt Cobain died 29 years ago today. He suffered chronic pain. Wrote in his journal that he chose drugs instead of ending his own life. Buprenorphine worked for him, as it does for many today. But it was illegal then. When his physician died in 93 he was caught off. RIP Kurdt

This program launched my academic career and also happened to be where I met some of my closest friends and colleagues. Check it out and feel free to reach out with questions.

“Responsibility without blame”- read 👇🏾, including comments from Michigan Research Chandra Sripada

NEW: Despite pandemic-era #healthpolicy changes designed to reduce barriers to buprenorphine prescribing to people with #opioid addiction, a new study in JAMA led by Kao-Ping Chua & Amy Bohnert shows little change since 2016: ihpi.umich.edu/news/study-tre…

As a mom of three, it takes a village to go to conferences. I am thankful to come home rejuvenated from meeting so many I admire at #SGIM2023 to grandparents, spoiled kiddos, soccer, and science olympiad.

For people with #ChronicPain who have been taking #opioids over the long term, a newly published expert consensus highlights the importance of #healthinsurance changes and provider education to enable multimodal pain care: ihpi.umich.edu/news/experts-c…

Read below ⬇️ Stefan Kertesz, MD, MSc and I discuss why the CDC recommendation to have shared decision making around “risks versus benefits” when on long term opioids is impossible as clinicians and patients more often than not have diametrically opposed views on “benefit.”

New pub NEJM: after elimination of the waiver requirement to prescribe buprenorphine, the # of prescribers increased, but the # of patients changed little. U-M IHPI CHEAR Rena Conti Mark Bicket, MD, PhD, FASA Pooja Lagisetty Thuy Nguyen Amy Bohnert NIDAnews nejm.org/doi/full/10.10…

Writing led by med student extraordinaire Emaun Irani University of Michigan Medical School

1/ New @JAMACurrent: using a regression discontinuity analysis that exploits changes in cost-sharing on Jan 1, we estimate a $10 increase in naloxone cost-sharing would decrease dispensing by 2.3%-3.1% in privately insured and Medicare patients. U-M IHPI jamanetwork.com/journals/jama/…